Association of H3K9me3 with breast cancer prognosis by estrogen receptor status.

MLA

Zhou, Meng, et al. “Association of H3K9me3 with Breast Cancer Prognosis by Estrogen Receptor Status.” Clinical Epigenetics, vol. 14, no. 1, Oct. 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s13148-022-01363-y.

APA

Zhou, M., Yan, J., Chen, Q., Yang, Y., Li, Y., Ren, Y., Weng, Z., Zhang, X., Guan, J., Tang, L., & Ren, Z. (2022). Association of H3K9me3 with breast cancer prognosis by estrogen receptor status. Clinical Epigenetics, 14(1), 1–7. https://doi.org/10.1186/s13148-022-01363-y

Chicago

Zhou, Meng, Jin-qi Yan, Qian-xin Chen, Yuan-zhong Yang, Yue-lin Li, Yue-xiang Ren, Zi-jin Weng, et al. 2022. “Association of H3K9me3 with Breast Cancer Prognosis by Estrogen Receptor Status.” Clinical Epigenetics 14 (1): 1–7. doi:10.1186/s13148-022-01363-y.